Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Cell and Gene Therapy Catapult

Advancing cell and gene therapies through powerful collaborations - Cell and Gene Therapy

Cell and Gene Therapy Catapult is a UK company with status active founded in 2016 based in London.

CRN

10016023

Founded

2016

Age

Overview

Legal name

CELL AND GENE THERAPY CATAPULT

Region

London

Registered address

12TH FLOOR TOWER WING GUY'S HOSPITAL

GREAT MAZE POND

LONDON

UNITED KINGDOM

SE1 9RT

Insolvency history

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller

Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Cell and Gene Therapy Catapult

CRN 10016023

Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC

Cell Therapy Catapult Limited

CRN 07964711

Latest accounts

Financial period: 1 Mar 2024 to 28 Feb 2025

FULLACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

Unknown

Company events

Reference milestones and recent Companies House filing stream events.

6 events

17 Feb

2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Nov

2026

Accounts due

Accounts Due

Next accounts due date

03 Feb

2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

28 Feb

2025

Accounts filed

Accounts

Last accounts made up date

11 Sep

2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzNTI0NDU0NWFkaXF6a2N4 | Paper/PDF filed

Published 12 Sep 2024 06:08

19 Feb

2016

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards

First funded

2017

Funded years

2017, 2018, 2021

Age at first award

1 years

Projects

2021 Collaborative R&D Lead participant

ATTC Coordination

1 Apr 2021 to 31 Mar 2022

Awarded

£302,929

Total cost £302,929

2021 Centres

Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics

1 Apr 2021 to 31 Mar 2022

Awarded

£13,887

Total cost £13,887

2018 Centres Lead participant

ISCF Funding for Advanced Therapy Manufacturing Apprenticeships

1 Jul 2018 to 30 Apr 2021

Awarded

£1,499,198

Total cost £1,499,198

Awaiting Public Project Summary

2018 Centres Lead participant

ATTC Coordination

1 Jun 2018 to 31 Mar 2022

Awarded

£1,706,975

Total cost £1,706,975

Awaiting Public Project Summary

2017 Centres Lead participant

ISCF Funding for Phase 2 of the C&GT Catapult Manufacturing Centre

1 Aug 2017 to 31 Oct 2019

Awarded

£10,000,000

Total cost £10,000,000

Awaiting Public Project Summary

Product types

Centres Collaborative R&D